Health
How SARS-CoV-2 variant B.1.1.7 adapted to evade innate immunity – News-Medical.Net
Researchers in the United States and the UK have conducted a study showing how the B.1.1.7 (Alpha) lineage of severe acute respiratory…
Researchers in the United States and the UK have conducted a study showing how the B.1.1.7 (Alpha) lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) adapted to suppress host innate immune responses in lung epithelial cells.
The SARS-CoV-2…
Continue Reading
-
Business18 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News15 hours agoWilliam Robinson dies aged 89
-
Business18 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.
-
Noosa News16 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats